Abstract
The social weight of elderly people, in particular women, has been increasing during the last hundred years in Europe as in other industrialized regions. During this period, female life expectancy rose, whereas the mean age at menopause remained constant, and the number of children per couple decreased, leading to a reversal of the classical age pyramid. Life expectancy of a modern 50-year-old woman is approximately 30 years. In 2020, over one billion individuals will be over 60. Geriatric patients represent a high percentage of the daily consultations of a family doctor. An economically acceptable prevention of the consequences of estrogen-deficiency will be mandatory. Therefore, menopause will be one of the main issues of public health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Calaf-Alsina J. Les estrogènes dans le traitement de la ménopause en Europe. Communication aux deuxièmes journées européennes de la Scté Fse de Gynécologie, Versailles, 13–16 octobre 1994.
Holte A, Mikkelsen A. The menopausal syndrome: A factor analytic replication. Maturitas 1991;13:193–293.
Koster A. Hormone replacement therapy in 51-year old Danish women. Maturitas 1990;12:345–46.
Lindgren R, Berg G, Hammarm A, Ziccon E. Hormonal replacement therapy and sexuality in a population of Swedish postmenopausal women. Acta Obstet Gynecol Scan 1993;72:292–97.
Oddens BJ, Boulet MJ, Lehert P, Visser AP. Has the climacteric been medicalized? A study on the use of medication for climateric complaints in four countries. Maturitas 1992; 15:171–81.
Oddens BJ, Boulet MJ, Lehert P, Visser AP. A study on the use of medication for climateric complaints in western Europe — II. Maturitas 1994;19:1–12.
Parazzini F, La Vecchia C, Negri E, et al. Determinants of estrogen replacement therapy use in northern Italy. Rev Epidém et Santé Publ 1993;50:147–52.
Southamer N, Visser AP, Oddens BJ, et al. Dutch general practitioners’ attitudes towards the climateric and its treatment. Europ J Obstet Gynaecol Reprod Biol 1993;50:147–52.
Topo P, Klaukka T, Hemminki E, et al. Use of hormone replacement therapy in 1976–1989 by 45-to 64 year-old Finnish women. J Epidemiol Comm Health 1991; 45:277–80.
Rozenbaum H. Menopause in Europe: State of the art. In: Birkhäuser MH, Rozenbaum H, editors. Menopause: Proceedings of the European Consensus Development Conference, Montreux, 1995. Editions ESKA: Paris, 1996: 13–19.
Wiklund I., Karlberg J, Mattson LA. Quality of life during transdermal oestradiol therapy in postmenopausal women. A double-blind, placebo-controlled study. Am J Obstet Gynecol 1993;168:824–30.
Paganini-Hill A, Henderson VW. Estrogen-deficiency and risk of Alzheimer’s disease in women. Am J Epidemiol 1994;140:256–61.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Birkhäuser, M.H. (1997). The Problem of Menopause in Europe. In: Paoletti, R., Crosignani, P.G., Kenemans, P., Samsioe, G., Soma, M.R., Jackson, A.S. (eds) Women’s Health and Menopause. Medical Science Symposia Series, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5560-1_1
Download citation
DOI: https://doi.org/10.1007/978-94-011-5560-1_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6343-2
Online ISBN: 978-94-011-5560-1
eBook Packages: Springer Book Archive